Related Experiment Video
Updated: Aug 6, 2026

Forward Genetic Approaches in Chlamydia trachomatis
Published on: October 23, 2013
Abstract:
In vitro study on C. psittaci and C. trachomatis demonstrates that pristinamycin is active in a very small dose. With 5 g/l, inclusions are rare. To study pristinamycin activity in vivo, we used mice infected IP with C. psittaci. Mortality in the control group was 70%. Three groups of mice received 25 mg/kg, 50 mg/kg and 100 mg/kg pristinamycin respectively. The antibiotic was active in the 100 mg/kg dosage which is the therapeutic dosage. Due to its action on Gonococcus, it would be of interest to study pristinamycin in patients with sexually transmitted disease.
Insights
Pristinamycin effectively combats Chlamydia psittaci in mice at a therapeutic dose. This antibiotic shows promise for treating Chlamydia trachomatis and sexually transmitted infections.
Area of Science:
- Microbiology
- Pharmacology
Context:
- Chlamydia psittaci and Chlamydia trachomatis are significant bacterial pathogens.
- Pristinamycin is an antibiotic with potential antimicrobial properties.
Purpose:
- To evaluate the in vitro and in vivo efficacy of pristinamycin against Chlamydia psittaci.
- To determine the therapeutic dosage of pristinamycin for Chlamydia infections.
Summary:
- In vitro studies showed pristinamycin's activity against C. psittaci and C. trachomatis at low concentrations.
- In vivo studies in mice infected with C. psittaci demonstrated that a 100 mg/kg dosage of pristinamycin was therapeutic, reducing mortality.
- The antibiotic was found to be active at the 100 mg/kg dosage, which is considered the therapeutic dosage.
Impact:
- Pristinamycin exhibits therapeutic potential for Chlamydia infections.
- Further research into pristinamycin for treating sexually transmitted diseases, including gonorrhea, is warranted.
Related Concept Videos
Sexually Transmitted Infections
Antimicrobial Effectiveness
Bacterial Phylum Chlamydiae
Trichomoniasis
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis

